SINGAPORE (The Straits Times/Asia News Network): The Covid-19 vaccine developed by Novavax has been approved for individuals here aged 18 and above, said the Health Sciences Authority (HSA) on Monday (Feb 14).
Singapore News - The Covid-19 vaccine developed by Novavax has been approved for individuals aged 18 and above, said the Health Sciences Authority (HSA) on Monday (Feb 14). HSA had granted interim authorisation to the for Nuvaxovid vaccine on Feb 3, 2022 under the Pandemic Special Access. Read more at www.tnp.sg
The Health Sciences Authority (HSA), in consultation with its Medicines Advisory Committee, granted interim authorisation under the Pandemic Special Access Route (PSAR) for Pfizer’s Paxlovid, a combination of two medicines, nirmatrelvir (the antiviral medicine) and ritonavir (to maintain the blood level of nirmatrelvir for antiviral efficacy).